Suchergebnisse - (Person:"Lui, Grace")

PubPharm (6)

1

Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Chan, G. | Lui, G. | Wong, C. | +6

2

Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes

enthalten in: JAMA network open | 2023

von Ma, B. | Yip, T. | Lui, G. | +8

3

Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalization in Community Coronavirus Disease 2019 Patients (COVID-19)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Yip, T. | Lui, G. | Lai, M. | +8

4

Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitis

enthalten in: The Journal of infection | 2022

von Lai, C. | Lui, G. | Wei, Y. | +9

CommentOn: J Infect. 2022 Jun;84(6):834-872. - PMID 35351541

5

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir

enthalten in: JAMA network open | 2022

von Wong, G. | Yip, T. | Lai, M. | +3

6

Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19

enthalten in: Gut | 2021

von Yip, T. | Lui, G. | Wong, V. | +7

1
[1]